Vetter Pharma Fertigung GmbH & Co. KG (Ravensburg Mooswiesen)February 9, 2018

FDA 483 - Vetter Pharma Fertigung GmbH & Co. KG (Ravensburg Mooswiesen) - February 09, 2018

View on Dashboard

Discuss this record with AI

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Vetter Pharma Fertigung GmbH & Co. KG (Ravensburg Mooswiesen)

Record Details

An FDA inspection of Vetter Pharma Fertigung Gmbg & Co. KG in Ravensburg, Germany, identified a significant issue regarding the firm's risk assessment processes. Specifically, the assessment supporting media fills lacked comprehensive details and evaluations. This indicates a moderate severity finding related to quality control and manufacturing practices.

Company: Vetter Pharma Fertigung GmbH & Co. KG (Ravensburg Mooswiesen)
Inspection Date: February 9, 2018
Product Type: Drugs
Office: Office of Inspections and Investigations
People: Thuy T. Nguyen ( Investigator, Consumer Safety Officer)
Michael R. Klapal (Investigator)

Open in Dashboard

ID · d2c2a04a-70fd-47d0-9898-d4c6ae6f5b44